USANA Health Sciences, Inc. USNA
Set alert
14.72 USD +0.41 +2.87%
At close · Nov 2
14.72 0.00 0.00%
After hours · Nov 2, 4:00 PM ET
14.43 Day range 14.90
12.57 52-week range 23.59
- YTD
- -25.01%
- 1 year
- -30.40%
- Open
- 14.51
- Prev close
- 14.31
- Mkt cap
- 271.97M
- Vol
- 175.94K
- Avg vol
- 211.96K
- EPS
- -1.20
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 14.43
- High
- 14.90
- Forward P/E
- 13.69
- Beta
- 0.89
- Short ratio
- 5.95
- Inst. own
- 57.64%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 4, 2025
- 50-d avg
- 37.85
- 200-d avg
- 42.19
- 1y target
- 46.50
1D chart
Signals (11)
| Name | Time | Ago |
|---|---|---|
| MACD: Sell Signal | 3:59 PM | 15 hours ago |
| RSI: Overbought | 3:51 PM | 15 hours ago |
| SMA: Bullish | 3:40 PM | 15 hours ago |
| SMA: Bullish | 3:40 PM | 15 hours ago |
| MACD: Buy Signal | 3:38 PM | 15 hours ago |
| SMA: Bearish | 2:31 PM | 17 hours ago |
| MACD: Sell Signal | 2:08 PM | 17 hours ago |
| SMA: Bullish | 12:50 PM | 18 hours ago |
| MACD: Buy Signal | 12:50 PM | 18 hours ago |
| MACD: Sell Signal | 12:06 PM | 19 hours ago |
| SMA: Bearish | 11:49 AM | 19 hours ago |
Analyst view
Consensus: none
Price target (mean) 46.50 +215.9% upside
Now 14.72
- Target (low)
- 35.00
- Target (mean)
- 46.50
- Target (high)
- 58.00
Ratings (0m) 1 0 buy · 1 hold · 0 sell
- Strong buy0
- Buy0
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 1
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.49 | 0.49 – 0.49 | 0.87 | -43.7% | 208.82M | -5.5% | 2 |
| Next quarter | 0.725 | 0.72 – 0.73 | 0.86 | -15.7% | 221.10M | -2.9% | 2 |
| Current year | 2.45 | 2.45 – 2.45 | 3.30 | -25.8% | 849.72M | -7.7% | 2 |
| Next year | 2.49 | 2.23 – 2.74 | 2.45 | +1.4% | 844.22M | -0.6% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 23, 2024 | DA Davidson | Maintained | Neutral | Neutral |
| Jul 25, 2024 | DA Davidson | Maintained | Neutral | Neutral |
| May 7, 2024 | DA Davidson | Maintained | Neutral | Neutral |
| Feb 22, 2024 | DA Davidson | Maintained | Neutral | Neutral |
| Oct 25, 2023 | DA Davidson | Maintained | Neutral | Neutral |
| Apr 26, 2023 | DA Davidson | Maintained | — | Neutral |
| Feb 13, 2023 | DA Davidson | Maintained | — | Neutral |
| Oct 27, 2022 | DA Davidson | Maintained | — | Neutral |
| Jul 28, 2022 | DA Davidson | Maintained | — | Neutral |
| Jul 12, 2022 | DA Davidson | Maintained | — | Neutral |
| Jul 7, 2022 | Jefferies | Downgrade | Hold | Underperform |
| Apr 27, 2022 | DA Davidson | Maintained | — | Neutral |
| Apr 14, 2022 | DA Davidson | Initiated | — | Neutral |
| Feb 10, 2021 | Roth Capital | Maintained | — | Buy |
| Dec 17, 2020 | Roth Capital | Initiated | — | Buy |
| Aug 22, 2019 | Jefferies | Initiated | — | Hold |
| Jul 3, 2019 | Sidoti & Co. | Downgrade | Buy | Neutral |
| Apr 16, 2019 | Tigress Financial | Initiated | — | Buy |
| Apr 23, 2018 | Pivotal Research | Downgrade | Buy | Hold |
| Jan 24, 2018 | Sidoti & Co. | Downgrade | Buy | Neutral |
| May 3, 2017 | Pivotal Research | Upgrade | Hold | Buy |
| May 1, 2017 | Pivotal Research | Downgrade | Buy | Hold |
| Feb 10, 2016 | DA Davidson | Downgrade | Buy | Neutral |
| Sep 16, 2015 | DA Davidson | Upgrade | Neutral | Buy |
| Aug 6, 2015 | DA Davidson | Downgrade | Buy | Neutral |
| Jun 26, 2015 | DA Davidson | Initiated | — | Buy |
| Apr 27, 2015 | Pivotal Research | Downgrade | Buy | — |
| Oct 20, 2014 | Pivotal Research | Initiated | — | Buy |
| Oct 17, 2014 | Canaccord Genuity | Maintained | — | Hold |
| Nov 8, 2013 | Sidoti & Co. | Upgrade | Neutral | Buy |